Enigma Life Sciences has established technology scouting tools and processes to identify emerging life sciences technologies and companies highly relevant to a customer’s specified field of interest. We are specialized in finding early stage, under the radar science and technology opportunities.
TECHNOLOGY VALUATION AND ACQUISITION
Valuation of intellectual property or emerging life sciences technologies tends to be very complex. We can assist in helping you to evaluate a realistic valuation for technologies or IP of interest to you, while at the same time providing guidance on the value of build or buy options.
COMPETITIVE STRATEGY
We can develop actionable technology intelligence on the competitive landscape of your environment. The results from our competitor technology intelligence analysis can help steer your competitive strategy to an optimal positioning.
BUSINESS DEVELOPMENT
In our business development work, we bring together all of our expertise (technology scouting, valuation, competitive strategy) to assist you with growing your business.
How to systematically keep track of potentially new technology opportunities or competitive threats ?
Enigma Approach
IDENTIFY BREAKTHROUGH, UNDER THE RADAR LIFE SCIENCES TECHNOLOGIES FOR COMPETITIVE ADVANTAGE
Custom Big Data analysis to identify breakthrough technologies
Our company has developed a process to rapidly perform a technology intelligence scan for technologies offering competitive advantage amidst a large background of thousands of related technologies (see Veugelers et al., Linking technology intelligence to open innovation. Technological Forecasting & Social Change 77 (2010) 335–343.).
We have established extensive Life Sciences company profile databases, allowing for quick searches for technologies and more (e.g. contacts, deal values etc…).
Our founders have performed technology scouting and market studies for over 10 years in multiple life sciences fields with very deep emerging technology and company expertise.
More than 1000
Over 10.000
More than 50.000 companies
More than 150.000 Scientists
About Us
Enigma Life Sciences was founded in 2017 by Mark Veugelers, PhD, MBA.
Mark has over 10 years experience in scouting for and enabling the adoption of novel life sciences technologies.
Mark obtained his PhD in Medical Sciences from K.U.Leuven in 2000.
After a 4 year Postdoc in Cornell University, New York City, he joined VIB in 2004.
During his time at VIB, he obtained an MBA from Vlerick in 2008.
After many years of successfully running a Technology Scouting and implementation program at VIB, Mark left VIB in 2017 in order to found Enigma Life Sciences.
We can already offer you valuable technology leads during our free customer intake session.
